Synthesis of chiral R/S-pseudopeptide-based Cu(ii) & Zn(ii) complexes for use in targeted delivery for antitumor therapy: enantiomeric discrimination with CT-DNA and pBR322 DNA hydrolytic cleavage mechanism-Reference-Cited by-同舟云学术

Synthesis of chiral R/S-pseudopeptide-based Cu(ii) & Zn(ii) complexes for use in targeted delivery for antitumor therapy: enantiomeric discrimination with CT-DNA and pBR322 DNA hydrolytic cleavage mechanism

Published:2017 Issue:11 Volume:7 Page:6587-6597
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Parveen Sabiha¹²³⁴,Tabassum Sartaj¹²³⁴,Arjmand Farukh¹²³⁴^ORCID

Affiliation:

1. Department of Chemistry

2. Aligarh Muslim University

3. Aligarh 202002

4. India

Abstract

The detailed mechanism of the hydrolytic cleavage pathway of 1S with pBR322 d DNA and the molecular docked model with DNA are shown below.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/RA/C6RA24770A

Reference43 articles.

1. Cancer Prevention

2. Ferrocifen type anti cancer drugs

3. The status of platinum anticancer drugs in the clinic and in clinical trials

4. Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy

5. Targeted Chemotherapy with Metal Complexes

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De novo design and preparation, structural details, and cytotoxic response of a new water soluble (2,2′–bipy)–(phenylalaninato)–μ–chlorido–copper(II) drug candidate against resistant cancer cells;Journal of Molecular Structure;2024-11

2. De novo design and preparation of Copper(II)–based chemotherapeutic anticancer drug candidates with Boc–glycine and N,N–donor ligands: DNA binding, cleavage profile, and cytotoxic therapeutic response against MCF–7, PC–3, and HCT–116 cells;Polyhedron;2024-09

3. DNA binding, cleavage and anticancer activity of a Zn(II)-Cu(II) hetero-dinuclear carbohydrazone complex containing the secondary ligand 1,10-phenanthroline;Results in Chemistry;2023-12

4. Development of new cobalt, copper, and zinc complexes of Schiff-base ligands as prospective chemotherapeutic agents;Polyhedron;2023-11

5. Molecular interaction of lysozyme with therapeutic drug azithromycin: Effect of sodium dodecyl sulfate on binding profile;International Journal of Biological Macromolecules;2023-07